Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.
Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
J Am Coll Cardiol. 2017 Oct 3;70(14):1689-1700. doi: 10.1016/j.jacc.2017.08.017.
Recommendations for physical activity in patients with stable coronary heart disease (CHD) are based on modest evidence.
The authors analyzed the association between self-reported exercise and mortality in patients with stable CHD.
A total of 15,486 patients from 39 countries with stable CHD who participated in the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) study completed questions at baseline on hours spent each week taking mild, moderate, and vigorous exercise. Associations between the volume of habitual exercise in metabolic equivalents of task hours/week and adverse outcomes during a median follow-up of 3.7 years were evaluated.
A graded decrease in mortality occurred with increased habitual exercise that was steeper at lower compared with higher exercise levels. Doubling exercise volume was associated with lower all-cause mortality (unadjusted hazard ratio [HR]: 0.82; 95% confidence interval [CI]: 0.79 to 0.85; adjusting for covariates, HR: 0.90; 95% CI: 0.87 to 0.93). These associations were similar for cardiovascular mortality (unadjusted HR: 0.83; 95% CI: 0.80 to 0.87; adjusted HR: 0.92; 95% CI: 0.88 to 0.96), but myocardial infarction and stroke were not associated with exercise volume after adjusting for covariates. The association between decrease in mortality and greater physical activity was stronger in the subgroup of patients at higher risk estimated by the ABC-CHD (Age, Biomarkers, Clinical-Coronary Heart Disease) risk score (p for interaction = 0.0007).
In patients with stable CHD, more physical activity was associated with lower mortality. The largest benefits occurred between sedentary patient groups and between those with the highest mortality risk.
稳定性冠心病(CHD)患者的体力活动推荐是基于有限的证据。
作者分析了稳定性 CHD 患者自我报告的运动与死亡率之间的关系。
共有来自 39 个国家的 15486 名稳定性 CHD 患者参加了 STABILITY(开始用达拉普利治疗稳定动脉粥样硬化斑块)研究,他们在基线时完成了每周进行轻度、中度和剧烈运动的时间。评估每周代谢当量任务小时数的习惯性运动量与中位数为 3.7 年的随访期间不良结局之间的关系。
随着习惯性运动的增加,死亡率呈逐渐下降趋势,在较低运动水平下下降幅度更大。运动量增加一倍与全因死亡率降低相关(未经调整的危险比 [HR]:0.82;95%置信区间 [CI]:0.79 至 0.85;调整协变量后,HR:0.90;95%CI:0.87 至 0.93)。这些关联对于心血管死亡率也是相似的(未经调整的 HR:0.83;95%CI:0.80 至 0.87;调整后的 HR:0.92;95%CI:0.88 至 0.96),但在调整协变量后,心肌梗死和中风与运动量无关。在 ABC-CHD(年龄、生物标志物、临床-冠心病)风险评分较高的患者亚组中,死亡率降低与体力活动增加之间的关联更强(交互作用 p 值=0.0007)。
在稳定性 CHD 患者中,更多的体力活动与更低的死亡率相关。最大的获益发生在久坐不动的患者群体和死亡率最高的患者群体之间。